Ananda Scientific

[Ananda Scientific @AnandaScience]

🗽 Ananda Scientific Team in NYC | June 3-4

With multiple catalysts on the horizon, this is an ideal time to reach out and chat about the impact we want to make in the the neuropsychiatric space.

Let's Connect!
📧 [email protected] 
📱 [phone]

[Ananda Scientific @AnandaScience]

Ananda Scientific is heading to the Bio Equity Conference in Bruges on May 12–14th!

Join CEO Sohail R. Zaidi on May 14 at 9:45 AM in Room 7+8 as he presents our latest progress in developing innovative PTSD treatments.

#BioEquity2025 #BiotechInnovation #PTSD #LifeSciences

[Ananda Scientific @AnandaScience]

Ananda Scientific’s CEO, Sohail Zaidi, and SVP, Christopher Moore will be attending LSX World Congress Europe this week in London!

If you’re in town, let’s connect – reach out to schedule a meeting & we look forward to great conversations!
#LSXWorld #LifeSciences #Biotech #PTSD

[Ananda Scientific @AnandaScience]

Ananda Scientific and the David Geffen School of Medicine, UCLA, is pleased to announce the commencement of a clinical trial evaluating Nantheia™ ATL5 for Smoking Cessation.

https://t.co/UuRPYzVNUZ

[Ananda Scientific @AnandaScience]

Ananda Scientific is pleased to announce the commencement of a new clinical trial evaluating Nantheia™ ATL5 in the treatment of Co-Occurring Opioid Use Disorder (OUD) and Chronic Pain at Yale School of Medicine.
https://t.co/XqyYB7NCoX

[Ananda Scientific @AnandaScience]

Ananda Scientific is strongly positioned to bring cannabinoid-based therapeutics to patients who need it most.

Our Investigational Drug product line, Nantheia™ is in FDA approved clinical trials for PTSD, Social Anxiety Disorder and Opioid Use Disorder. #FDA #Clinical #Trial

[Ananda Scientific @AnandaScience]

We are pleased to announce that the first patient has been recruited in the FDA approved Clinical Trial evaluating Ananda’s investigational drug, Nantheia™ ATL5 for Opioid Use Disorder (OUD) at UCLA. #cannabinoid #science #pharmaceutical #FDA

https://t.co/0566NfzDhm

[Ananda Scientific @AnandaScience]

Ananda Scientific’s Liquid Structure™ Technology is a powerful delivery technology that makes Cannabinoids water soluble, shelf life stable for up to 2 years, and more rapidly absorbed into the bloodstream. #cannabinoid #pharmaceuticals #research #liquidstructure #Nantheia

[Ananda Scientific @AnandaScience]

Ananda Scientific was very pleased to host its Annual Shareholders’ Meeting this week. The shareholders were provided with an update on its six ongoing FDA approved clinical trials. Together we strive to create something meaningful and lasting. #FDA #clinicaltrial #ananda #cbd

[Ananda Scientific @AnandaScience]

We have reached an impressive milestone with 6 ongoing FDA approved Clinical Trials for PTSD, Opioid Use Disorder, Social Anxiety Disorder and Radiculopathic Pain management! Stay up to date with all our ongoing trials by visiting: https://t.co/2E3hyG3VnE

#FDA #clinicaltrials

[Ananda Scientific @AnandaScience]

Ananda Scientific has one core mission: To pioneer high caliber #clinical studies to evaluate some the most debilitating conditions our society faces. Through evidence based #research, Ananda Scientific plans to become the World leader in #Cannabinoid pharmaceutical development.

[Ananda Scientific @AnandaScience]

Social Anxiety Disorder (SAD) affects approximately 200,000 Americans a year. Ananda Scientific has been working over the years to develop products to treat SAD. We strive to provide a treatment option for this condition. #anandascientific #nantheia #socialanxietydisorder #SAD

[Ananda Scientific @AnandaScience]

Ananda Scientific and the University of Nebraska Medical Center announce FDA approval of the IND for a PTSD trial. The study will investigate the effectiveness and safety of Nantheia™ (Clinical Trials .Gov Identifier: NCT05269459) #anandascientific #fda

https://t.co/szCuNqEqqN

[Ananda Scientific @AnandaScience]

10 million. This is the number of Americans estimated to have abused prescription pain medication within the last year. An FDA trial is underway to evaluate our CBD based drug, Nantheia™ on Opioid Use Disorder. #anandascientific #CBD #UCLA

https://t.co/0tjeae4zMe

[Ananda Scientific @AnandaScience]

CEO Today has recognized Ananda Scientific for its groundbreaking innovation and research that can impact the lives of many suffering from debilitating conditions. #Anandascientific #CEOToday #Innovation #Cannabinoids #pharmaceuticals

https://t.co/oC7HdGpnKi

[Ananda Scientific @AnandaScience]

True to our mission of providing health and wellness through the power of cannabinoid science, we are actively researching ways to provide relief to the millions of Americans suffering from Social Anxiety Disorder. #socialanxiety #cannabinoids #health #wellness #ananda

[Ananda Scientific @AnandaScience]

The persistent dread or anxiety of being judged or rejected in a social setting is known as Social Anxiety Disorder (SAD). SAD is highly prevalent with rates exceeding 20 % in the United States alone. Ananda Scientific’s science team is working towards developing therapies.

[Ananda Scientific @AnandaScience]

Dr. Nissim Garti was recently recognized as being in the Top 15 Chemistry Scientists in Israel. He is the inventor of the Liquid Structure™ technology that is used in Ananda’s investigational drug, Nantheia™. #chemistry #technology #nantheia #cannabinoids #ananda

[Ananda Scientific @AnandaScience]

Ananda Scientific has partnered with the NYU School of Medicine in examining the effect of our investigational drug, Nantheia™ ATL5 on Radiculopathic Pain and Opioid Sparing. Subject recruitment for this trial is underway. #FDA #Clinical #Ananda #Cannabinoids#Nantheia#OUD

[Ananda Scientific @AnandaScience]

The need for safe and non-addictive medication for patients with Chronic pain has never been greater. According to the American Pain Society, chronic pain constitutes the greatest economic burden of any medical condition.